(Sharecast News) - Medical cannabis specialist Celadon Pharmaceuticals announced on Friday that it has raised £2.1m to provide it with additional working capital.
The AIM-traded firm raised the funds through a placing and subscription of two million new shares at a price of 105p each, representing a premium of 3.4% to...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE